Literature DB >> 27347083

Effect of kidney-reinforcing and marrow-beneficial Chinese medicine on bone metabolism-related factors following spinal cord injury in rats.

DA-An Zhou1, Yue Ning Deng2, Lei Liu2, Jian Jun Li3.   

Abstract

The present study aimed to investigate the effect of traditional Chinese kidney reinforcing and marrow-beneficial medicine (KRMB) on the prevention and treatment of abnormal bone metabolism and osteoporosis (OP) resulting from spinal cord injury (SCI). Rat models of OP following SCI were surgically established. The rats were randomly divided into five groups: Normal; sham operation + KRMB; normal + KRMB; SCI + KRMB; and SCI model group. Bone mineral density (BMD), and the expression of bone gamma-carboxyglutamic-acid containing protein (BGP), hepcidin mRNA and bone sialoprotein (BSP) were recorded at 1, 2, 4, 6, 8 and 10 weeks after the operation. BMD expression in the SCI model group was significantly lower compared with the normal, sham + KRMB and normal + KRMB groups at 4, 6, 8 and 10 weeks (P<0.01), and was significantly lower than that in the SCI + KRMB group at 6 (P<0.05), 8 and 10 weeks (P<0.01). The level of serum BGP in the SCI model group was significantly higher compared with the normal, sham + KRMB and normal + KRMB groups at each time point (P<0.01), and lower than the SCI + KRMB group (P<0.01). The SCI + KRMB group was significantly higher than the normal, sham operation + KRMB and normal + KRMB groups (P<0.01). Hepcidin mRNA expression in the rat livers in the normal, sham + KRMB and normal + KRMB group was significantly higher than that in the SCI + KRMB group and SCI model group at each time point (P<0.01). Hepcidin mRNA expression in the SCI + KRMB group was significantly higher than that in the SCI model group at 1 week (P<0.01), and significantly higher than the SCI model group at 2, 4, 6, 8 and 10 weeks (P<0.01). BSP expression in the SCI model group was significantly higher than that in the normal, sham + KRMB and normal + KRMB groups at each time point (P<0.01). BSP expression in SCI model group was higher than that in the SCI + KRMB group at 1 (P<0.05), 2, 4, 6, 8 and 10 weeks (P<0.01). In conclusion, KRMB traditional Chinese medicine may have a curative effect on secondary OP resulting from SCI.

Entities:  

Keywords:  bone metabolism; bone metabolism related factors; kidney-reinforcing and marrow-beneficial traditional Chinese medicine; spinal cord injury

Year:  2016        PMID: 27347083      PMCID: PMC4907026          DOI: 10.3892/etm.2016.3304

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

Review 1.  Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.

Authors:  Pierre J Marie; Moustapha Kassem
Journal:  Eur J Endocrinol       Date:  2011-05-04       Impact factor: 6.664

2.  Theoretical study of bone sialoprotein in bone biomineralization.

Authors:  Yang Yang; Donald Mkhonto; Qiang Cui; Nita Sahai
Journal:  Cells Tissues Organs       Date:  2011-05-19       Impact factor: 2.481

Review 3.  Concise review: human pluripotent stem cells in the treatment of spinal cord injury.

Authors:  Dunja Lukovic; Victoria Moreno Manzano; Miodrag Stojkovic; Shom Shanker Bhattacharya; Slaven Erceg
Journal:  Stem Cells       Date:  2012-09       Impact factor: 6.277

4.  Development of a database for translational spinal cord injury research.

Authors:  Jessica L Nielson; Cristian F Guandique; Aiwen W Liu; Darlene A Burke; A Todd Lash; Rod Moseanko; Stephanie Hawbecker; Sarah C Strand; Sharon Zdunowski; Karen-Amanda Irvine; John H Brock; Yvette S Nout-Lomas; John C Gensel; Kim D Anderson; Mark R Segal; Ephron S Rosenzweig; David S K Magnuson; Scott R Whittemore; Dana M McTigue; Phillip G Popovich; Alexander G Rabchevsky; Stephen W Scheff; Oswald Steward; Grégoire Courtine; V Reggie Edgerton; Mark H Tuszynski; Michael S Beattie; Jacqueline C Bresnahan; Adam R Ferguson
Journal:  J Neurotrauma       Date:  2014-07-31       Impact factor: 5.269

Review 5.  Serum bone sialoprotein levels and bone metastases.

Authors:  Mario Uccello; Giulia Malaguarnera; Marco Vacante; Massimo Motta
Journal:  J Cancer Res Ther       Date:  2011 Apr-Jun       Impact factor: 1.805

Review 6.  Measurement of Bone: Diagnosis of SCI-Induced Osteoporosis and Fracture Risk Prediction.

Authors:  Karen L Troy; Leslie R Morse
Journal:  Top Spinal Cord Inj Rehabil       Date:  2015-11-16

7.  Bone loss caused by iron overload in a murine model: importance of oxidative stress.

Authors:  Jaime Tsay; Zheiwei Yang; F Patrick Ross; Susanna Cunningham-Rundles; Hong Lin; Rhima Coleman; Philipp Mayer-Kuckuk; Stephen B Doty; Robert W Grady; Patricia J Giardina; Adele L Boskey; Maria G Vogiatzi
Journal:  Blood       Date:  2010-06-16       Impact factor: 22.113

8.  Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Authors:  Francesca Rossi; Silverio Perrotta; Giulia Bellini; Livio Luongo; Chiara Tortora; Dario Siniscalco; Matteo Francese; Marco Torella; Bruno Nobili; Vincenzo Di Marzo; Sabatino Maione
Journal:  Haematologica       Date:  2014-09-12       Impact factor: 9.941

9.  Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.

Authors:  Shin-Jen Lin; Hsin-Chiu Ho; Yi-Fen Lee; Ning-Chun Liu; Su Liu; Gonghui Li; Chih-Rong Shyr; Chawnshang Chang
Journal:  Reprod Biol Endocrinol       Date:  2012-06-07       Impact factor: 5.211

10.  Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.

Authors:  Sacide Atalay; Abdullah Elci; Huseyin Kayadibi; Can B Onder; Nurettin Aka
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.